LRP8 Antikörper (C-Term)
Kurzübersicht für LRP8 Antikörper (C-Term) (ABIN363502)
Target
Alle LRP8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 863-963, C-Term
-
Spezifität
- Reacts with mouse LRP-8 protein
-
Aufreinigung
- Purified
-
Immunogen
- Synthetic peptide made to a C-terminal portion of the human ApoER2 protein sequence (between residues 863-963)
-
-
-
-
Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only:
- WB : 2 μg/mL -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Tris-glycine, NaCl 150 mM buffer, Sodium azide 0.05 %
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Short term storage at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
-
Haltbarkeit
- 6 months
-
-
- LRP8 (Low Density Lipoprotein Receptor-Related Protein 8, Apolipoprotein E Receptor (LRP8))
-
Andere Bezeichnung
- Low-Density Lipoprotein Receptor-Related Protein 8 (LRP-8)
Target
-